RECIST 1.1 AND irRC FOR RESPONSE ASSESMENT IN PATIENTS WITH DISSEMINATED CUTANEOUS MELANOMA TREATED WITH IPILIMUMAB OR DENDRITIC CELL VACCINE
暂无分享,去创建一个
S. Protsenko | D. Latipova | I. Baldueva | A. Novik | A. Semenova | A. Novik | E. Yaremenko | E. M. Anokhina | A. I. Semenova | S. Protsenko | I. Baldueva | E. V. Yaremenko | E. M. Anokhina | T. L. Nehaeva